Immediate Impact
2 by Nobel laureates 4 from Science/Nature 54 standout
Citing Papers
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
2023 Standout
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
2022 Standout
Works of Mark R. Bowles being referenced
Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by Human Liver Carboxylesterase
1996
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mark R. Bowles | 346 | 77 | 67 | 145 | 21 | 541 | |
| Yue-Li Sun | 238 | 38 | 66 | 220 | 21 | 510 | |
| Jane Hamlett | 270 | 41 | 96 | 124 | 27 | 605 | |
| Keun Na | 352 | 44 | 51 | 86 | 25 | 611 | |
| Gaëlle Noé | 235 | 24 | 58 | 184 | 25 | 584 | |
| Stefan Müllner | 337 | 63 | 17 | 143 | 30 | 641 | |
| Anthony J. Chubb | 278 | 62 | 107 | 78 | 24 | 599 | |
| D E Pollet | 217 | 83 | 93 | 85 | 16 | 581 | |
| Robert G. Pietrusko | 197 | 35 | 28 | 122 | 15 | 588 | |
| J. E. Sodergren | 268 | 31 | 35 | 119 | 12 | 559 | |
| Jingchun Gao | 320 | 20 | 47 | 139 | 19 | 595 |
All Works
Loading papers...